Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs

Name: Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

infections

infections, meningococcal

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158025
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.